|
1
|
Prevention of mouse lung tumors by budesonide and its modulation of biomarkers.
|
Carcinogenesis
|
2002
|
1.03
|
|
2
|
Reversibility of aberrant global DNA and estrogen receptor-alpha gene methylation distinguishes colorectal precancer from cancer.
|
Int J Clin Exp Pathol
|
2008
|
0.93
|
|
3
|
DNA hypomethylation induced by non-genotoxic carcinogens in mouse and rat colon.
|
Cancer Lett
|
2004
|
0.88
|
|
4
|
Modulation by celecoxib and difluoromethylornithine of the methylation of DNA and the estrogen receptor-alpha gene in rat colon tumors.
|
Carcinogenesis
|
2004
|
0.87
|
|
5
|
Modulation by bexarotene of mRNA expression of genes in mouse lung tumors.
|
Mol Carcinog
|
2008
|
0.81
|
|
6
|
Modulation by budesonide of DNA methylation and mRNA expression in mouse lung tumors.
|
Int J Cancer
|
2007
|
0.81
|
|
7
|
Retracted
Prevention of mouse lung tumors and modulation of DNA methylation by combined treatment with budesonide and R115777 (Zarnestra MT).
|
Carcinogenesis
|
2006
|
0.81
|
|
8
|
Prevention by methionine of dichloroacetic acid-induced liver cancer and DNA hypomethylation in mice.
|
Toxicol Sci
|
2003
|
0.78
|
|
9
|
Prevention of mouse lung tumors and modulation of DNA methylation by combined treatment with budesonide and R115777 (ZarnestraMT).
|
Carcinogenesis
|
2006
|
0.77
|
|
10
|
Modulation by budesonide of a CpG endonuclease in mouse lung tumors.
|
Carcinogenesis
|
2007
|
0.77
|
|
11
|
Effect of peroxisome proliferators on the methylation and protein level of the c-myc protooncogene in B6C3F1 mice liver.
|
J Biochem Mol Toxicol
|
2002
|
0.76
|
|
12
|
Effects of budesonide on overall 5-methylcytosine levels and specific methylation and messenger RNA expression of the insulin-like growth factor II gene in mouse lung tumors.
|
Chest
|
2004
|
0.75
|